SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-001975
Filing Date
2021-10-01
Accepted
2021-10-01 16:06:09
Documents
12
Period of Report
2021-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ziop-20211001.htm   iXBRL 8-K 44793
  Complete submission text file 0000950170-21-001975.txt   164363

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ziop-20211001_pre.xml EX-101.PRE 10282
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ziop-20211001_lab.xml EX-101.LAB 14020
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ziop-20211001.xsd EX-101.SCH 2475
5 EXTRACTED XBRL INSTANCE DOCUMENT ziop-20211001_htm.xml XML 4957
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 211298915
SIC: 2834 Pharmaceutical Preparations